このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Paysign マネジメント

マネジメント基準チェック /44

Paysign'sの CEO はMark Newcomerで、 Mar2006年に任命され、の在任期間は 18.25年です。の年間総報酬は$ 1.21Mで、 78.7%給与と21.3%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の17.87%を直接所有しており、その価値は$ 36.93M 。経営陣と取締役会の平均在任期間はそれぞれ3.7年と6.1年です。

主要情報

Mark Newcomer

最高経営責任者

US$1.2m

報酬総額

CEO給与比率	78.7%
CEO在任期間	18.3yrs
CEOの所有権	17.9%
経営陣の平均在職期間	3.8yrs
取締役会の平均在任期間	6.2yrs

経営陣の近況

Recent updates

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

CEO報酬分析

Paysign の収益と比較して、Mark Newcomer の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	US$7m
Dec 31 2023	US$1m	US$950k	US$6m
Sep 30 2023	n/a	n/a	US$2m
Jun 30 2023	n/a	n/a	US$1m
Mar 31 2023	n/a	n/a	US$1m
Dec 31 2022	US$3m	US$950k	US$1m
Sep 30 2022	n/a	n/a	US$420k
Jun 30 2022	n/a	n/a	-US$703k
Mar 31 2022	n/a	n/a	-US$1m
Dec 31 2021	US$963k	US$950k	-US$3m
Sep 30 2021	n/a	n/a	-US$7m
Jun 30 2021	n/a	n/a	-US$13m
Mar 31 2021	n/a	n/a	-US$12m
Dec 31 2020	US$1m	US$950k	-US$9m
Sep 30 2020	n/a	n/a	-US$3m
Jun 30 2020	n/a	n/a	US$6m
Mar 31 2020	n/a	n/a	US$8m
Dec 31 2019	US$1m	US$883k	US$7m
Sep 30 2019	n/a	n/a	US$6m
Jun 30 2019	n/a	n/a	US$4m
Mar 31 2019	n/a	n/a	US$3m
Dec 31 2018	US$875k	US$650k	US$3m
Sep 30 2018	n/a	n/a	US$2m
Jun 30 2018	n/a	n/a	US$2m
Mar 31 2018	n/a	n/a	US$2m
Dec 31 2017	US$552k	US$424k	US$2m

報酬と市場: Markの総報酬 ($USD 1.21M ) は、 US市場 ($USD 1.58M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Markの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Mark Newcomer (59 yo)

18.3yrs

在職期間

US$1,207,659

報酬

Mr. Mark R. Newcomer is a Co-Founder of PaySign, Inc., (formerly known as 3Pea International, Inc.) and serves as its President from January 24, 2024 and has been its Chief Executive Officer and Director s...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Mark Newcomer	Co-Founder	18.3yrs	US$1.21m	17.87% $ 37.6m
Jeffery Baker	CFO & Treasurer	3.4yrs	US$572.02k	0.30% $ 623.7k
Robert Strobo	General Counsel	5.8yrs	US$574.65k	0.33% $ 696.7k
Cosimo Cambi	Chief Operating Officer	less than a year	データなし	データなし
Brad Cunningham	Chief Technology Officer	3yrs	データなし	データなし
James McCroy	Executive Vice President of Strategic Development/IR	no data	データなし	データなし
Eric Trudeau	Chief Compliance Officer	6.4yrs	データなし	データなし
Dennis DiVenuta	Executive Vice President of Strategy & Corporate Development	6.3yrs	データなし	データなし
Alicia Ches	Director of Marketing	no data	データなし	データなし
Joan Herman	Executive VP of EFT Operations & Executive Director	3.4yrs	データなし	1.47% $ 3.1m
Matthew Lanford	Chief Payments Officer & Director	less than a year	データなし	0.17% $ 351.2k
Matthew Turner	President of Patient Affordability	4.1yrs	データなし	データなし

3.8yrs

平均在職期間

57yo

平均年齢

経験豊富な経営陣: PAYSの経営陣は経験豊富であると考えられます ( 3.7年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Mark Newcomer	Co-Founder	18.3yrs	US$1.21m	17.87% $ 37.6m
Joan Herman	Executive VP of EFT Operations & Executive Director	5.7yrs	データなし	1.47% $ 3.1m
Matthew Lanford	Chief Payments Officer & Director	1.9yrs	データなし	0.17% $ 351.2k
Daniel Henry	Independent Director	6.2yrs	US$125.20k	0.15% $ 317.6k
Jeffrey Newman	Independent Director	1.6yrs	US$125.20k	0.057% $ 119.1k
Dennis Triplett	Non-Executive Independent Director	6.2yrs	US$125.20k	0.43% $ 913.1k
Alexander Goldberg	Member of Advisory Board	9.8yrs	データなし	データなし
Leonard Goodman	Member of Advisory Board	9.8yrs	データなし	データなし
Bruce Mina	Non-Executive Independent Director	6.3yrs	US$125.20k	0.45% $ 946.8k

6.2yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: PAYSの取締役会は経験豊富であると考えられます ( 6.1年の平均在任期間)。

Paysign マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

Independent Director exercised options to buy US$85k worth of stock.

PaySign, Inc., Annual General Meeting, May 03, 2024

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Co-Founder exercised options and sold US$71k worth of stock

CFO & Treasurer recently sold US$101k worth of stock

Recent updates

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

PaySign, Inc. Provides Earnings Guidance for the Full Year of 2022

Price target decreased to US$3.44

Insufficient new directors

Price target decreased to US$3.44

Insufficient new directors

PaySign: A 'Backdoor' $2 Stagflation Play

Paysign: My Top Rebound Pick For 2022

Paysign: The Plasma Toll Booth

PaySign's Post-Pandemic Payoff

PaySign, Inc.(NasdaqCM:PAYS) dropped from Russell 2000 Defensive Index

PaySign, Inc. Provides Earnings Guidance for the Full Year 2021

Paysign, Inc. Announces Retirement of Joan M. Herman, as Chief Operating Officer

Why PaySign Is A Very Good Company

PaySign: Long-Term Story Still Intact

PaySign, Inc. and ImmunoTek Bio Centers LLC Collaborate in Support of COVID-19 Convalescent Plasma Collection

PaySign, Inc. announced delayed 10-Q filing